View/Open

Date

Format

Metadata

Abstract

Patients with type 2 diabetes who aren't on insulin and perform self-monitoring of blood glucose (SMBG) show small but significant reductions in hemoglobin A1c (HbA1c) at 6 months but not at 12 months (strength of recommendation [SOR]: B, systematic reviews and meta-analyses of disease-oriented evidence).
Patients with a baseline HbA1c <8% who self-monitor don't reduce their HbA1c levels, but patients with a baseline HbA1c >8% do (SOR: B, systematic reviews and meta-analyses of disease-oriented evidence). More frequent SMBG—4 to 7 times weekly—doesn't reduce HbA1c more than less frequent self-monitoring—1 or 2 times a week (SOR: B, a systematic review and
meta-analysis of disease-oriented evidence).